Human umbilical cord blood (HUCB) derived CD34+ stem cells can exhibit neuronal or glial cell properties under defined culture conditions [1] and have been reported to mediate therapeutic effects in animal model of stroke [2,3]. The gene discussed is CD34; the disease is stroke disorder.